The journey to saving lives from accidental overdoses starts now. That way, no parent, friend, or relative has to get a phone call from the hospital about a loved one overdosing ever again.
MabLab's approach combines cutting-edge technology with existing studies in the life sciences. In fact, MabLab uses monoclonal antibodies — the same technology used in COVID-19 tests. The validation and testing of our scientific innovation have been carried out through a strategic collaboration with staff scientists and professors at both Harvard University and Columbia University.